Canada markets close in 1 hour 38 minutes

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.3000+0.3600 (+9.14%)
As of 01:48PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 36.35M
Enterprise Value -14.31M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.63
Enterprise Value/Revenue -3.43
Enterprise Value/EBITDA 0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-57.13%
S&P500 52-Week Change 325.77%
52 Week High 310.5000
52 Week Low 33.9400
50-Day Moving Average 34.6453
200-Day Moving Average 36.6486

Share Statistics

Avg Vol (3 month) 313.33k
Avg Vol (10 day) 33.89k
Shares Outstanding 59.23M
Implied Shares Outstanding 69.44M
Float 85.93M
% Held by Insiders 119.13%
% Held by Institutions 138.41%
Shares Short (Apr 15, 2024) 425.62k
Short Ratio (Apr 15, 2024) 42.2
Short % of Float (Apr 15, 2024) 40.37%
Short % of Shares Outstanding (Apr 15, 2024) 40.28%
Shares Short (prior month Mar 15, 2024) 420.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 05, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,187.90%

Management Effectiveness

Return on Assets (ttm)-35.29%
Return on Equity (ttm)-95.51%

Income Statement

Revenue (ttm)2.24M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)-85.90%
Gross Profit (ttm)N/A
EBITDA -34.42M
Net Income Avi to Common (ttm)-42.19M
Diluted EPS (ttm)-7.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.57M
Total Cash Per Share (mrq)6.13
Total Debt (mrq)5.91M
Total Debt/Equity (mrq)10.31%
Current Ratio (mrq)5.45
Book Value Per Share (mrq)6.21

Cash Flow Statement

Operating Cash Flow (ttm)-25.12M
Levered Free Cash Flow (ttm)-17.95M